Cite
Rosecrans A, Harris R, Saxton RE, et al. Mobile low-threshold buprenorphine integrated with infectious disease services. J Subst Abuse Treat. 2021;108553doi: 10.1016/j.jsat.2021.108553.
Rosecrans, A., Harris, R., Saxton, R. E., Cotterell, M., Zoltick, M., Willman, C., Blackwell, I., Bell, J., Hayes, D., Weir, B., Sherman, S., Lucas, G. M., Greenbaum, A., & Page, K. R. (2021). Mobile low-threshold buprenorphine integrated with infectious disease services. Journal of substance abuse treatment, 108553. https://doi.org/10.1016/j.jsat.2021.108553
Rosecrans, Amanda, et al. "Mobile low-threshold buprenorphine integrated with infectious disease services." Journal of substance abuse treatment vol. (2021): 108553. doi: https://doi.org/10.1016/j.jsat.2021.108553
Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, Blackwell I, Bell J, Hayes D, Weir B, Sherman S, Lucas GM, Greenbaum A, Page KR. Mobile low-threshold buprenorphine integrated with infectious disease services. J Subst Abuse Treat. 2021 Jun 24;108553. doi: 10.1016/j.jsat.2021.108553. Epub 2021 Jun 24. PMID: 34238629.
Copy
Download .nbib